Holen Sie sich die Stockscreener-App
0.80
4.14%
0.0318
Handel nachbörslich:
.80
Schlusskurs vom Vortag:
$0.7682
Offen:
$0.763
24-Stunden-Volumen:
297.95K
Relative Volume:
0.23
Marktkapitalisierung:
$1.50M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+0.13%
1M Leistung:
-49.69%
6M Leistung:
-83.67%
1J Leistung:
-94.54%
1-Tages-Spanne:
$0.763
$0.82
1-Wochen-Bereich:
$0.6685
$0.82
52-Wochen-Spanne:
$0.662
$17.93
Psyence Biomedical Ltd Stock (PBM) Company Profile
Firmenname
Psyence Biomedical Ltd
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie PBM mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PBM
Psyence Biomedical Ltd
|
0.80 | 1.44M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
463.86 | 119.17B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
796.55 | 84.19B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
398.29 | 52.77B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
788.49 | 48.98B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.97 | 36.31B | 447.02M | -1.18B | -906.14M | -6.1812 |
Psyence Biomedical Ltd Aktie (PBM) Neueste Nachrichten
How Psyence Biomedical Ltd. stock performs in weak economyJuly 2025 Selloffs & Risk Adjusted Buy and Sell Alerts - ulpravda.ru
Comparing Compugen (NASDAQ:CGEN) & Psyence Biomedical (NASDAQ:PBM) - Defense World
Is Psyence Biomedical Ltd. stock attractive for hedge fundsWeekly Trade Report & Expert Curated Trade Setup Alerts - ulpravda.ru
Surprises Report: Will Psyence Biomedical Ltd. Equity Warrant stock gain from strong economyJuly 2025 Breakouts & Daily Price Action Insights - ulpravda.ru
Will Psyence Biomedical Ltd. stock benefit from infrastructure spendingJuly 2025 PostEarnings & Reliable Breakout Forecasts - ulpravda.ru
Why Psyence Biomedical Ltd. stock could benefit from AI revolutionWeekly Stock Summary & Daily Growth Stock Tips - ulpravda.ru
What valuation multiples suggest for Psyence Biomedical Ltd. Equity Warrant stockQuarterly Investment Review & Reliable Intraday Trade Alerts - ulpravda.ru
Psyence Biomedical Calls January 22, 2026 Shareholder Meeting to Vote on Financials, Board and Share Consolidation - TipRanks
How currency fluctuations impact Psyence Biomedical Ltd. Equity Warrant stock2025 Trading Volume Trends & Low Volatility Stock Recommendations - ulpravda.ru
Can Psyence Biomedical Ltd. stock rebound after recent weaknessWeekly Trade Report & Reliable Intraday Trade Alerts - ulpravda.ru
Will Psyence Biomedical Ltd. Equity Warrant stock deliver consistent dividendsMarket Activity Recap & Weekly Breakout Watchlists - ulpravda.ru
Why Psyence Biomedical Ltd. Equity Warrant stock appeals to analystsWeekly Stock Analysis & Expert Verified Stock Movement Alerts - ulpravda.ru
What is the fair value of Psyence Biomedical Ltd. stock now2025 Pullback Review & Entry and Exit Point Strategies - ulpravda.ru
How Psyence Biomedical Ltd. stock reacts to oil pricesWeekly Earnings Recap & Technical Confirmation Trade Alerts - ulpravda.ru
Psyence Biomedical Ltd.Ordinary Shares (NQ: PBM - FinancialContent
Psyence Biomedical announces milestone in natural ibogaine HCl production - TipRanks
Psyence Biomedical Ltd. Announces Board Changes - MarketScreener
Psyence BioMed Achieves Milestone in Natural Ibogaine HCl Production and Strengthens Balance Sheet With No Debt and $12m Cash - The Manila Times
Psyence BioMed Achieves Milestone in Natural Ibogaine HCl - GlobeNewswire
Published on: 2026-01-04 19:06:08 - Early Times
Investment Recap: Why Psyence Biomedical Ltd Equity Warrant stock appeals to analystsCPI Data & Real-Time Market Sentiment Alerts - moha.gov.vn
Gainers Report: Why Psyence Biomedical Ltd stock could benefit from AI revolutionSell Signal & Real-Time Chart Pattern Alerts - moha.gov.vn
Corporate Update: Psyence Biomedical Ltd Redefines Psychedelic Medicine with a Multi-Asset Strategy, Advancing Clinical Trials and Scalable Manufacturing - TMX Newsfile
Psyence Biomedical (NASDAQ:PBM) Trading Down 6.1% – Here’s Why - Defense World
Published on: 2025-12-20 18:04:24 - Улправда
Will Psyence Biomedical Ltd. stock benefit from upcoming earnings reportsJuly 2025 Decliners & Technical Buy Zone Confirmations - Улправда
Investment Review: Is Psyence Biomedical Ltd. stock attractive for hedge fundsDay Trade & Safe Capital Growth Plans - moha.gov.vn
Psyence Biomedical’s psilocybin approved for Phase IIb trial use By Investing.com - Investing.com Nigeria
{Company Name} Stock Soars on Exciting Developments - StocksToTrade
Psyence Biomedical stock rises after ethics approval for psilocybin trial By Investing.com - Investing.com South Africa
Psyence Biomedical stock rises after ethics approval for psilocybin trial - Investing.com India
Psyence Biomedical Ltd. Announces Approval for Use of Psylabs' Psilocybin Product in Phase IIb Clinical Trial - MarketScreener
Psyence BioMed Announces Approval for Use of PsyLabs’ Psilocybin Product in Phase IIb Clinical Trial - The Manila Times
Psyence BioMed announces approval for use of Psylabs' psilocybin product in phase IIb clinical trial - marketscreener.com
Psyence Biomedical’s psilocybin approved for Phase IIb trial use - Investing.com
Psyence BioMed Announces Approval For Use Of Psylabs’ Psilocybin Product In Phase IIb Clinical Trial - TradingView — Track All Markets
Will Psyence Biomedical Ltd. Equity Warrant stock gain from government policies2025 Institutional Moves & Stock Timing and Entry Methods - Улправда
New Highs: Will Psyence Biomedical Ltd. stock benefit from upcoming earnings reportsForecast Cut & Real-Time Sentiment Analysis - Улправда
Will Psyence Biomedical Ltd. stock beat EPS estimatesPortfolio Performance Report & Low Risk Entry Point Tips - ulpravda.ru
Why Psyence Biomedical Ltd. Equity Warrant stock is popular among millennialsWeekly Gains Report & Fast Gaining Stock Strategy Reports - Улправда
Is Psyence Biomedical Ltd. Equity Warrant stock dividend yield sustainableJuly 2025 Selloffs & Weekly Consistent Profit Watchlists - Улправда
Why Psyence Biomedical Ltd. Equity Warrant stock remains a top recommendation2025 Bull vs Bear & Low Risk High Reward Trade Ideas - Улправда
How geopolitical tensions affect Psyence Biomedical Ltd. stock2025 Trading Recap & AI Powered Trade Plan Recommendations - Улправда
Psyence Biomedical Ltd. (PBM) -5.7% in After-hours: Despite No Clear Catalyst - Stocks Telegraph
Psyence BioMed Advances Phase IIb Clinical Trial and Expands Board - MSN
Check out these key findings about Psyence Biomedical Ltd (PBM) - setenews.com
Rapid Surge: Psyence Biomedical’s Unexpected Stock Movement - StocksToTrade
Psyence BioMed (PBM) Stock: Drives Forward with Phase IIb Trial and Unique Longevity Science Position - parameter.io
Psyence Biomedical Ltd. (PBM) Stock: Drops, But Company Pushes Forward with Groundbreaking Psychedelic Therapies - parameter.io
Psyence BioMed CEO Letter Highlights Clinical Progress, Ethical sourcing of Ibogaine, Strong Cash Position and Expanding Leadership in Longevity Science - Asianet Newsable
Psyence BioMed CEO Letter Highlights Clinical Progress, Ethical Sourcing of Ibogaine, Strong Cash Position and Expanding Leadership in Longevity Science - The Manila Times
Finanzdaten der Psyence Biomedical Ltd-Aktie (PBM)
Es liegen keine Finanzdaten für Psyence Biomedical Ltd (PBM) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.90%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):